These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21352847)

  • 1. Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the rat.
    Bertaina-Anglade V; Drieu-La-Rochelle C; Mocaër E; Seguin L
    Pharmacol Biochem Behav; 2011 Jun; 98(4):511-7. PubMed ID: 21352847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
    Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
    Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
    Chagraoui A; Protais P; Filloux T; Mocaër E
    Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.
    Soumier A; Banasr M; Lortet S; Masmejean F; Bernard N; Kerkerian-Le-Goff L; Gabriel C; Millan MJ; Mocaer E; Daszuta A
    Neuropsychopharmacology; 2009 Oct; 34(11):2390-403. PubMed ID: 19571795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
    Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
    Millan MJ; Brocco M; Gobert A; Dekeyne A
    Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.
    Ladurelle N; Gabriel C; Viggiano A; Mocaër E; Baulieu EE; Bianchi M
    Psychopharmacology (Berl); 2012 Jun; 221(3):493-509. PubMed ID: 22160164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.
    Bertaina-Anglade V; la Rochelle CD; Boyer PA; Mocaër E
    Behav Pharmacol; 2006 Dec; 17(8):703-13. PubMed ID: 17110796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of agomelatine in the chronic mild stress model of depression in the rat.
    Papp M; Gruca P; Boyer PA; Mocaër E
    Neuropsychopharmacology; 2003 Apr; 28(4):694-703. PubMed ID: 12655314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.
    Bourin M; Mocaër E; Porsolt R
    J Psychiatry Neurosci; 2004 Mar; 29(2):126-33. PubMed ID: 15069466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration.
    Molteni R; Calabrese F; Pisoni S; Gabriel C; Mocaer E; Racagni G; Riva MA
    World J Biol Psychiatry; 2010 Mar; 11(2):148-53. PubMed ID: 20109111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain.
    Chenu F; El Mansari M; Blier P
    Neuropsychopharmacology; 2013 Jan; 38(2):275-84. PubMed ID: 22871919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
    Schmelting B; Corbach-Söhle S; Kohlhause S; Schlumbohm C; Flügge G; Fuchs E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):437-47. PubMed ID: 23978391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons.
    Chenu F; Shim S; El Mansari M; Blier P
    J Psychopharmacol; 2014 Feb; 28(2):162-7. PubMed ID: 24189440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythms, melatonin and depression.
    Quera Salva MA; Hartley S; Barbot F; Alvarez JC; Lofaso F; Guilleminault C
    Curr Pharm Des; 2011; 17(15):1459-70. PubMed ID: 21476953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
    Rainer Q; Xia L; Guilloux JP; Gabriel C; Mocaër E; Hen R; Enhamre E; Gardier AM; David DJ
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):321-35. PubMed ID: 21473810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats.
    Conboy L; Tanrikut C; Zoladz PR; Campbell AM; Park CR; Gabriel C; Mocaer E; Sandi C; Diamond DM
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):329-41. PubMed ID: 18706130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agomelatine, a melatonin agonist with antidepressant properties.
    Dubovsky SL; Warren C
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1533-40. PubMed ID: 19758108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agomelatine: innovative pharmacological approach in depression.
    Popoli M
    CNS Drugs; 2009; 23 Suppl 2():27-34. PubMed ID: 19708723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.